Vascular access for intravenous chemotherapy: totally implanted systems.
This is a prospective study conducted in order to evaluate totally implanted venous access systems. The report concerning 42 patients is presented. The follow-up is 5 to 17 months (median 9 months). A variety of antineoplastic agents were administered through the device. Complications rarely occur and after utilization all patients are still treated in this way. Physician-, nurse- and patient-acceptance were excellent and this system appears to improve the quality of life style of cancer patients.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002408:Catheters, Indwelling; D006801:Humans; D007275:Injections, Intravenous / Q000295:instrumentation / Q000379:methods; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents